Pharmaceutical, Clinical, and Resistance Information on Doravirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection

Drugs in Context - United Kingdom
doi 10.7573/dic.2019-11-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BioExcel

Related search

Development of a Vaginal Delivery Film Containing EFdA, a Novel Anti-Hiv Nucleoside Reverse Transcriptase Inhibitor

International Journal of Pharmaceutics
Pharmaceutical Science
2014English

Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan

PLoS ONE
Multidisciplinary
2017English

Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients

AIDS Research and Treatment
ImmunologyPublic HealthAllergyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2015English

New Indolylarylsulfones as Highly Potent and Broad Spectrum HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2014English

Viral Resuppression and Detection of Drug Resistance Following Interruption of a Suppressive Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimen

AIDS
Infectious DiseasesAllergyImmunology
2008English

Mechanisms of Inhibition of HIV Replication by Non-Nucleoside Reverse Transcriptase Inhibitors

Virus Research
Cancer ResearchVirologyInfectious Diseases
2008English

Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
2003English

Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Minority Variants Associated With Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy